Library
Selegiline increases the actions of dopamine in the brain by inhibiting the enzymes that break it down. After being sold for years as an anti-aging supplement and a treatment for Parkinson's disease, the FDA approved use of a Selegiline transdermal patch (Emsam) for treatment of depression in 2006.
Also known as: إمسام, زيلابر, ديبرينيل, إلدبريل
No data available for this section yet.
No route information available yet.
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
